Add BrightSurf on Google Email

American Thoracic Society


As wildfires increase in severity, experts call for coordinated federal response

The American Thoracic Society releases a report highlighting the need for research on wildfire smoke's effects on respiratory and cardiovascular health, as well as communication strategies to protect public health. The report emphasizes the importance of coordinated federal response and dedicated funding to mitigate health risks.

SourceAmerican Thoracic Society·JournalAnnals of the American Thoracic Society·DateMay 3, 2021

Home oxygen therapy for adults with COPD and ILD: New ATS clinical practice guideline

The new ATS clinical practice guideline provides comprehensive guidance on long-term and ambulatory oxygen therapy for adults with COPD and ILD. The guideline recommends LTOT for severe chronic resting room air hypoxemia in both COPD and ILD patients, and suggests ambulatory oxygen for moderate exertional room air hypoxemia in COPD pat...

SourceAmerican Thoracic Society·JournalAmerican Journal of Respiratory and Critical Care Medicine·DateNov 17, 2020

Face masks unlikely to cause over-exposure to CO2, even in patients with lung disease

A study published in the Annals of the American Thoracic Society found that wearing face masks has minimal impact on gas exchange in healthy individuals and those with severe lung impairment. The researchers stress the importance of wearing masks to prevent COVID-19 infection, especially for patients with lung disease.

SourceAmerican Thoracic Society·JournalAnnals of the American Thoracic Society·DateOct 2, 2020

Challenges in diagnosing hypersensitivity pneumonitis addressed in latest guidelines

The American Thoracic Society and its collaborators have developed new clinical practice guidelines for diagnosing hypersensitivity pneumonitis, a condition that manifests as interstitial lung disease. The guidelines aim to standardize clinical care and facilitate research by providing a framework for clinicians to make accurate diagno...

SourceAmerican Thoracic Society·JournalAmerican Journal of Respiratory and Critical Care Medicine·DateAug 3, 2020

Experts strongly recommend varenicline over the patch for adult smokers hoping to quit

The American Thoracic Society's new guideline recommends varenicline as the optimal controller medication for clinicians to use initially in treating tobacco dependence. Introducing varenicline before a patient expresses willingness to quit results in an additional 308 patients achieving abstinence.

SourceAmerican Thoracic Society·JournalAmerican Journal of Respiratory and Critical Care Medicine·DateJul 15, 2020

First official ATS practice guidelines for Sarcoidosis cover diagnosis and detection

The American Thoracic Society has published its first official guidelines for diagnosing sarcoidosis, an inflammatory disease affecting the lungs and other organs. The guidelines recommend a baseline serum test to screen for hypercalcemia, as well as conditional tests for specific symptoms and organ involvement.

SourceAmerican Thoracic Society·JournalAmerican Journal of Respiratory and Critical Care Medicine·DateApr 20, 2020

ECMO physicians offer guidance in the context of resource-scarce COVID-19 treatment

In the context of a resource-scarce COVID-19 treatment, ECMO physicians outline their approach to care and provide guidelines for medical centers to respond to patients' needs. The guidance emphasizes optimizing resource utilization to prioritize patients with severe respiratory failure but without other significant co-morbidities.

SourceAmerican Thoracic Society·JournalAnnals of the American Thoracic Society·DateApr 15, 2020

New study identifies characteristics of patients with fatal COVID-19

Researchers identified common characteristics of COVID-19 patients who died in Wuhan, China, including high mortality rates among males over 50 with chronic diseases. The study found that respiratory failure, shock, and cardiac arrhythmia were leading causes of death, highlighting the importance of early detection and treatment.

SourceAmerican Thoracic Society·JournalAmerican Journal of Respiratory and Critical Care Medicine·DateApr 3, 2020

Three-drug combination reduces COPD patient mortality

A new study published in the American Journal of Respiratory and Critical Care Medicine reports that a three-drug combination of fluticasone furoate, umeclidinium, and vilanterol reduces all-cause mortality by 42% in patients with chronic obstructive pulmonary disease (COPD) treated with an inhaler once daily.

SourceAmerican Thoracic Society·JournalAmerican Journal of Respiratory and Critical Care Medicine·DateMar 18, 2020

Lung microbiome may help predict outcomes in critically ill patients

Research suggests that lung bacteria can predict clinical outcomes in critically ill patients, with certain bacteria associated with worse outcomes and the presence of gut-associated bacteria found in the lungs. The study's findings have implications for developing new therapies to prevent and treat critical illness.

SourceAmerican Thoracic Society·JournalAmerican Journal of Respiratory and Critical Care Medicine·DateJan 24, 2020

Study finds disparity in critical care deaths between non-minority and minority hospitals

A recent study published in the American Journal of Respiratory and Critical Care Medicine found a significant disparity in critical care deaths between non-minority and minority hospitals. Critically ill African American patients were more likely to experience poorer outcomes, with nearly a third treated at only 14 hospitals.

SourceAmerican Thoracic Society·JournalAmerican Journal of Respiratory and Critical Care Medicine·DateJan 17, 2020

New clinical guideline for the treatment and prevention of drug-resistant tuberculosis

The American Thoracic Society has published a new clinical guideline for the treatment and prevention of drug-resistant tuberculosis, emphasizing the use of all-oral regimens. The guideline also recommends treatment for all contacts of MDR-TB patients and provides evidence-based guidance for pregnant women with MDR-TB.

SourceAmerican Thoracic Society·JournalAmerican Journal of Respiratory and Critical Care Medicine·DateNov 18, 2019